Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study.
Kraft
George H
GH
Bowen
James
J
D001559:Benzhydryl Compounds / Q000008:administration & dosage*; D000697:Central Nervous System Stimulants / Q000008:administration & dosage; D003866:Depressive Disorder / Q000150:complications / Q000523:psychology; D003951:Diagnostic Errors / Q000517:prevention & control*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D015673:Fatigue Syndrome, Chronic / Q000188:drug therapy* / Q000209:etiology* / Q000523:psychology; D006801:Humans; D000077408:Modafinil; D009103:Multiple Sclerosis / Q000150:complications* / Q000503:physiopathology / Q000523:psychology; D018579:Patient Selection; D015990:Placebo Effect; D016032:Randomized Controlled Trials as Topic / Q000592:standards / Q000706:statistics & numerical data; D012893:Sleep Wake Disorders / Q000139:chemically induced / Q000150:complications; D017211:Treatment Failure
D001559:Benzhydryl Compounds; D000697:Central Nervous System Stimulants; D000077408:Modafinil